Tailored Atrial Substrate Modification Based on Low-Voltage Areas in Catheter Ablation of Atrial FibrillationSascha Rolf, Christopher Piorkowski, Simon Kircher et al.|Circulation Arrhythmia and Electrophysiology|2014Cited by 561
Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Nonischemic Cardiomyopathy Compared With Ischemic CardiomyopathyBorislav Dinov, Arash Arya, Lukas Fiedler et al.|Circulation|2013Cited by 380
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD studyJohan Sundström, Navdeep Tangri, Johan Bodegård et al.|The Lancet Regional Health - Europe|2022Cited by 315
The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillationJelena Kornej, Andreas Bollmann, Gerhard Hindricks et al.|Clinical Research in Cardiology|2015Cited by 226
Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH scoreJędrzej Kosiuk, Sascha Rolf, Borislav Dinov et al.|Heart Rhythm|2015Cited by 202